(19)
(11) EP 2 451 444 A1

(12)

(43) Date of publication:
16.05.2012 Bulletin 2012/20

(21) Application number: 09790099.7

(22) Date of filing: 07.07.2009
(51) International Patent Classification (IPC): 
A61K 9/20(2006.01)
A61K 31/495(2006.01)
(86) International application number:
PCT/US2009/049768
(87) International publication number:
WO 2011/005250 (13.01.2011 Gazette 2011/02)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR

(71) Applicant: Sunovion Pharmaceuticals Inc.
Marlborough, MA 01752 (US)

(72) Inventors:
  • HSIA, Richard
    Boston, MA 02118 (US)
  • CAPILA, Priya
    Ashland, MA 01721 (US)
  • BAI, Ge
    Marlborough, MA 01752 (US)
  • MISRA, Tushar
    Norfolk, VA 02056 (US)

(74) Representative: Cooke, Richard Spencer 
Elkington and Fife LLP Prospect House 8 Pembroke Road
Sevenoaks, Kent TN13 1XR
Sevenoaks, Kent TN13 1XR (GB)

   


(54) FORMULATIONS OF 6- (5-CHLORO-2-PYRIDYL) - 5- [ (4-METHYL-1-PIPERAZINYL) CARBONYLOXY]- 7-0X0-6, 7- DIHYDRO- 5H- PHYRROLO [3, 4-B]PYRAZINE